Joseph M. Vinetz, X. Frank Yang, Derrick E. Fouts, Douglas E. Berg, Rudy A. Hartskeerl, Alejandro Buschiazzo, Daniel H. Haft, Albert I. Ko, Dieter M. Bulach, Jun-Jie Zhang, Ana L. T. O. Nascimento, Janjira Thaipandungpanit, Luciane Amorim-Santos, Bernhard O. Palsson, Sharon J. Peacock, Mathieu Picardeau, Ariel E. Mechaly, Jonathan M. Monk, Ben Adler, David A. Haake, Haritha Adhikarla, James Matsunaga, Elsio A. Wunder, Karen E. Nelson, Michael A. Matthias, Yung Fu Chang, Paul N. Levett, Jessica N. Ricaldi, Renee L. Galloway, J. Craig Venter Institute [La Jolla, USA] (JCVI), Division of Infectious Diseases - Department of Medicine, University of California [San Diego] (UC San Diego), University of California (UC)-University of California (UC), Department of Epidemiology of Microbial Disease [New Haven], Yale School of Public Health (YSPH), Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University [Clayton], Instituto Gonçalo Moniz / Gonçalo Moniz Research Centre - Fiocruz Bahia [Salvador, Brésil] (IGM), Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ), Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Victorian Bioinformatics Consortium [Clayton], Institut Pasteur de Montevideo, Réseau International des Instituts Pasteur (RIIP), Département de Biologie structurale et Chimie - Department of Structural Biology and Chemistry, Institut Pasteur [Paris] (IP), Department of Population Medicine and Diagnostic Sciences, Cornell University [New York], Centers for Disease Control and Prevention [Atlanta] (CDC), Centers for Disease Control and Prevention, David Geffen School of Medicine [Los Angeles], University of California [Los Angeles] (UCLA), Veterans Affairs Greater Los Angeles Health Care System, National Collaborating Centre for Reference and Research on Leptospirosis [Pays-bas], The Royal Tropical Institute (KIT), Disease Control Laboratory Regina, Government of Saskatchewan, Department of Bioengineering, Centro de Biotecnologia [Sao Paulo], Instituto Butantan [São Paulo], Instituto de ciencias biomedicas (ICB-USP), Universidade de São Paulo = University of São Paulo (USP), Department of Medicine [Cambridge], University of Cambridge [UK] (CAM), Biologie des Spirochètes / Biology of Spirochetes, Instituto de Medicina Tropical 'Alexander von Humboldt' (IMT AvH), Universidad Peruana Cayetano Heredia (UPCH), Faculty of Tropical Medicine, Mahidol University [Bangkok], Department of Microbiology and Immunology [Indianapolis], Indiana University School of Medicine, Indiana University System-Indiana University System, This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Contract Number HHSN272200900007C. Thiswork was also supported in part by the following U.S. Public Health Service grants: U19AI115658 (JMV), R01AI108276 (JMV), D43TW007120 (JMV), K24AI068903 (JMV), R21AI115273 (MAM), R01AI052473 (AIK), U01AI088752 (AIK), R25TW009338 (AIK), R01TW009504 (AIK), and R01AI121207 (AIK). In addition, support to the A. Buschiazzo team was provided in part by grantsFSA_1_2013_1_12557 and ALI_1_2014_1_4982 from ANII (Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., We are grateful to the J. Craig Venter Institute sequencing, bioinformatics and IT departments for supporting the infrastructure required to determine the genome sequences, annotation and pan-genome and other analyses carried out in this project., University of California-University of California, Fundação Oswaldo Cruz (FIOCRUZ), Institut Pasteur [Paris], Universidade de São Paulo (USP), and Small, Pamela LC
Leptospirosis, caused by spirochetes of the genus Leptospira, is a globally widespread, neglected and emerging zoonotic disease. While whole genome analysis of individual pathogenic, intermediately pathogenic and saprophytic Leptospira species has been reported, comprehensive cross-species genomic comparison of all known species of infectious and non-infectious Leptospira, with the goal of identifying genes related to pathogenesis and mammalian host adaptation, remains a key gap in the field. Infectious Leptospira, comprised of pathogenic and intermediately pathogenic Leptospira, evolutionarily diverged from non-infectious, saprophytic Leptospira, as demonstrated by the following computational biology analyses: 1) the definitive taxonomy and evolutionary relatedness among all known Leptospira species; 2) genomically-predicted metabolic reconstructions that indicate novel adaptation of infectious Leptospira to mammals, including sialic acid biosynthesis, pathogen-specific porphyrin metabolism and the first-time demonstration of cobalamin (B12) autotrophy as a bacterial virulence factor; 3) CRISPR/Cas systems demonstrated only to be present in pathogenic Leptospira, suggesting a potential mechanism for this clade’s refractoriness to gene targeting; 4) finding Leptospira pathogen-specific specialized protein secretion systems; 5) novel virulence-related genes/gene families such as the Virulence Modifying (VM) (PF07598 paralogs) proteins and pathogen-specific adhesins; 6) discovery of novel, pathogen-specific protein modification and secretion mechanisms including unique lipoprotein signal peptide motifs, Sec-independent twin arginine protein secretion motifs, and the absence of certain canonical signal recognition particle proteins from all Leptospira; and 7) and demonstration of infectious Leptospira-specific signal-responsive gene expression, motility and chemotaxis systems. By identifying large scale changes in infectious (pathogenic and intermediately pathogenic) vs. non-infectious Leptospira, this work provides new insights into the evolution of a genus of bacterial pathogens. This work will be a comprehensive roadmap for understanding leptospirosis pathogenesis. More generally, it provides new insights into mechanisms by which bacterial pathogens adapt to mammalian hosts., Author Summary Leptospirosis is an emerging and re-emerging globally important zoonotic infectious disease caused by spirochetes of the genus Leptospira. This genus is complex, with members that cause lethal human disease, yet mechanisms that underlie pathogenesis remain obscure. Leptospira species are divided into those that are infectious for mammals, and those that are non-infectious environmental saprophytes. Based on biological characteristics and molecular phylogeny, infectious Leptospira are further divided into pathogenic and intermediately pathogenic members. The pan-genus genomic analysis of 20 Leptospira species reported here shows the evolutionary relationship of the different Leptospira clades, and various genetic factors related to virulence and pathogenesis. Infectious Leptospira show key adaptations to mammals, for example sialic acid biosynthesis, pathogen-specific porphyrin metabolism, and the observation that pathogenic Leptospira are vitamin B12 autotrophs, able to synthesize it from a simple amino acid precursor, L-glutamine. A large novel protein family of unknown function—the Virulence Modifying proteins—is found uniquely in pathogenic Leptospira. Similarly, the CRISPR/Cas system was only found in pathogenic Leptospira. A comparative genomic analysis of a complex bacterial genus allowed us to identify large-scale changes that provides new insights into general processes by which bacteria evolve to become pathogenic.